|
|
 |
 |
|
Peter R. Carroll, MD, MPH
Recent Publications |
Publications – 2009 |
 |
Breyer, B.N., J.M. Whitson, P.R.
Carroll,
and B.R. Konety, Sequential intravesical gemcitabine and
mitomycin C chemotherapy regimen in patients with non-muscle
invasive bladder cancer. Urol Oncol, 2009. |
|
Cantarovich, M., A. Hirsh, A. Alam,
N. Giannetti, R. Cecere, P. Carroll, and M.E. Edwardes, The
clinical impact of an early decline in kidney function in
patients following heart transplantation. Am J Transplant,
2009. 9(2): p. 348-54. |
|
Karl, A., P.R. Carroll, J.E. Gschwend,
R. Knuchel, F. Montorsi, C.G. Stief, and U.E. Studer, The
Impact of Lymphadenectomy and Lymph Node Metastasis on the
Outcomes of Radical Cystectomy for Bladder Cancer. Eur Urol,
2009. |
|
Konety, B.R., M.R. Cooperberg, and P.R.
Carroll, Are age-based criteria the best way to determine
eligibility for prostate cancer screening? Ann Intern Med,
2009. 150(3): p. 220-1; author reply 221-2. |
|
Odisho, A.Y., V. Fradet, M.R. Cooperberg,
A.E. Ahmad, and P.R. Carroll, Geographic distribution of
urologists throughout the United States using a county level
approach. J Urol, 2009. 181(2): p. 760-5; discussion 765-6. |
| |
Publications – 2008 |
|
Agarwal, P.K., N. Sadetsky, B.R.
Konety, M.I. Resnick, and P.R. Carroll, Treatment failure
after primary and salvage therapy for prostate cancer: likelihood,
patterns of care, and outcomes. Cancer, 2008. 112(2): p.
307-14. |
|
Arredondo, S.A., T.M. Downs, D.P. Lubeck,
D.J. Pasta, S.J. Silva, K.L. Wallace, and P.R. Carroll, Watchful
waiting and health related quality of life for patients with
localized prostate cancer: data from CaPSURE. J Urol, 2008.
179(5 Suppl): p. S14-8. |
|
Barocas, D.A., J.E. Cowan, J.A. Smith,
Jr., and P.R. Carroll, What percentage of patients with newly
diagnosed carcinoma of the prostate are candidates for surveillance?
An analysis of the CaPSURE database. J Urol, 2008. 180(4):
p. 1330-4; discussion 1334-5. |
|
Bellizzi, K.M., D.M. Latini, J.E. Cowan,
J. DuChane, and P.R. Carroll, Fear of recurrence, symptom
burden, and health-related quality of life in men with prostate
cancer. Urology, 2008. 72(6): p. 1269-73. |
|
Cabrera, A.R., F.V. Coakley, A.C. Westphalen,
Y. Lu, S. Zhao, K. Shinohara, P.R. Carroll, and J. Kurhanewicz,
Prostate cancer: is inapparent tumor at endorectal MR and
MR spectroscopic imaging a favorable prognostic finding in
patients who select active surveillance? Radiology, 2008.
247(2): p. 444-50. |
|
Choueiri, T.K., R. Dreicer, A. Paciorek,
P.R. Carroll, and B. Konety, A model that predicts the probability
of positive imaging in prostate cancer cases with biochemical
failure after initial definitive local therapy. J Urol, 2008.
179(3): p. 906-10; discussion 910. |
|
Chung, C.S., M.H. Chen, J. Cullen, D.
McLeod, P. Carroll, and A.V. D'Amico, Time to prostate-specific
antigen nadir after androgen suppression therapy for postoperative
or postradiation PSA failure and risk of prostate cancer-specific
mortality. Urology, 2008. 71(1): p. 136-40. |
|
Cooperberg, M.R., J. Cowan, J.M. Broering,
and P.R. Carroll, High-risk prostate cancer in the United
States, 1990-2007. World J Urol, 2008. 26(3): p. 211-8. |
|
Cooperberg, M.R., K. Mallin, J. Ritchey,
J.D. Villalta, P.R. Carroll, and C.J. Kane, Decreasing size
at diagnosis of stage 1 renal cell carcinoma: analysis from
the National Cancer Data Base, 1993 to 2004. J Urol, 2008.
179(6): p. 2131-5. |
|
Dall'era, M.A., M.R. Cooperberg, J.M.
Chan, B.J. Davies, P.C. Albertsen, L.H. Klotz, C.A. Warlick,
L. Holmberg, D.E. Bailey, Jr., M.E. Wallace, P.W. Kantoff,
and P.R. Carroll, Active surveillance for early-stage prostate
cancer: review of the current literature. Cancer, 2008. |
|
Dall'Era, M.A., M.R. Cooperberg, J.M.
Chan, B.J. Davies, P.C. Albertsen, L.H. Klotz, C.A. Warlick,
L. Holmberg, D.E. Bailey, Jr., M.E. Wallace, P.W. Kantoff,
and P.R. Carroll, Active surveillance for early-stage prostate
cancer: review of the current literature. Cancer, 2008. 112(8):
p. 1650-9. |
|
Dall'Era, M.A., B.R. Konety, J.E. Cowan,
K. Shinohara, F. Stauf, M.R. Cooperberg, M.V. Meng, C.J.
Kane, N. Perez, V.A. Master, and P.R. Carroll, Active surveillance
for the management of prostate cancer in a contemporary cohort.
Cancer, 2008. 112(12): p. 2664-70. |
|
Davies, B.J., T.J. Walsh, P.L. Ross,
S.J. Knight, N. Sadetsky, P.R. Carroll, and C.J. Kane, Effect
of BMI on Primary Treatment of Prostate Cancer. Urology,
2008. |
|
Frattaroli, J., G. Weidner, A.M. Dnistrian,
C. Kemp, J.J. Daubenmier, R.O. Marlin, L. Crutchfield, L.
Yglecias, P.R. Carroll, and D. Ornish, Clinical events in
prostate cancer lifestyle trial: results from two years of
follow-up. Urology, 2008. 72(6): p. 1319-23. |
|
Hart, S.L., D.M. Latini, J.E. Cowan,
and P.R. Carroll, Fear of recurrence, treatment satisfaction,
and quality of life after radical prostatectomy for prostate
cancer. Support Care Cancer, 2008. 16(2): p. 161-9. |
|
Hong, Y.M., J.C. Hu, A.T. Paciorek,
S.J. Knight, and P.R. Carroll, Impact of radical prostatectomy
positive surgical margins on fear of cancer recurrence: Results
from CaPSUREtrade mark. Urol Oncol, 2008. |
|
Isbarn, H., L. Boccon-Gibod, P.R. Carroll,
F. Montorsi, C. Schulman, M.R. Smith, C.N. Sternberg, and
U.E. Studer, Androgen Deprivation Therapy for the Treatment
of Prostate Cancer: Consider Both Benefits and Risks. Eur
Urol, 2008. |
|
Kane, C.J., K. Mallin, J. Ritchey,
M.R. Cooperberg, and P.R. Carroll, Renal cell cancer stage
migration: analysis of the National Cancer Data Base. Cancer,
2008. 113(1): p. 78-83. |
|
Konety, B.R., J.E. Cowan, and P.R.
Carroll, Patterns of primary and secondary therapy for prostate
cancer in elderly men: analysis of data from CaPSURE. J Urol,
2008. 179(5): p. 1797-803; discussion 1803. |
|
Kurhanewicz, J., D. Vigneron, P. Carroll,
and F. Coakley, Multiparametric magnetic resonance imaging
in prostate cancer: present and future. Curr Opin Urol, 2008.
18(1): p. 71-7. |
|
Lee, I.H., N. Sadetsky, P.R. Carroll,
and H.M. Sandler, The impact of treatment choice for localized
prostate cancer on response to phosphodiesterase inhibitors.
J Urol, 2008. 179(3): p. 1072-6; discussion 1076. |
|
Macdonald, O.K., A.V. D'Amico, N. Sadetsky,
D.C. Shrieve, and P.R. Carroll, Predicting PSA failure following
salvage radiotherapy for a rising PSA post-prostatectomy:
from the CaPSURE database. Urol Oncol, 2008. 26(3): p. 271-5. |
|
Marberger, M., P.R. Carroll, M.J. Zelefsky,
J.A. Coleman, H. Hricak, P.T. Scardino, and L.L. Abenhaim,
New treatments for localized prostate cancer. Urology, 2008.
72(6 Suppl): p. S36-43. |
|
Ornish, D., J. Lin, J. Daubenmier,
G. Weidner, E. Epel, C. Kemp, M.J. Magbanua, R. Marlin, L.
Yglecias, P.R. Carroll, and E.H. Blackburn, Increased telomerase
activity and comprehensive lifestyle changes: a pilot study.
Lancet Oncol, 2008. 9(11): p. 1048-57. |
|
Ornish, D., M.J. Magbanua, G. Weidner,
V. Weinberg, C. Kemp, C. Green, M.D. Mattie, R. Marlin, J.
Simko, K. Shinohara, C.M. Haqq, and P.R. Carroll, Changes
in prostate gene expression in men undergoing an intensive
nutrition and lifestyle intervention. Proc Natl Acad Sci
U S A, 2008. 105(24): p. 8369-74. |
|
Paris, P.L., S. Sridharan, A.B. Hittelman,
Y. Kobayashi, S. Perner, G. Huang, J. Simko, P. Carroll,
M.A. Rubin, and C. Collins, An oncogenic role for the multiple
endocrine neoplasia type 1 gene in prostate cancer. Prostate
Cancer Prostatic Dis, 2008. |
|
Sadetsky, N., E.P. Elkin, D.M. Latini,
J. DuChane, and P.R. Carroll, Prostate cancer outcomes among
older men: insurance status comparisons results from CaPSURE
database. Prostate Cancer Prostatic Dis, 2008. 11(3): p.
280-7. |
|
Sadetsky, N., D.P. Lubeck, D.J. Pasta,
D.M. Latini, J. DuChane, and P.R. Carroll, Insurance and
quality of life in men with prostate cancer: data from the
Cancer of the Prostate Strategic Urological Research Endeavor.
BJU Int, 2008. 101(6): p. 691-7. |
|
Sartor, A.O., H. Hricak, T.M. Wheeler,
J. Coleman, D.F. Penson, P.R. Carroll, M.A. Rubin, and P.T.
Scardino, Evaluating localized prostate cancer and identifying
candidates for focal therapy. Urology, 2008. 72(6 Suppl):
p. S12-24. |
|
Shah, J.B., J.M. McKiernan, E.P. Elkin,
P.R.
Carroll, and M.V. Meng, Prostate biopsy patterns in
the CaPSURE database: evolution with time and impact on outcome
after prostatectomy. J Urol, 2008. 179(1): p. 136-40. |
|
Simone, N.L., A.K. Singh, J.E. Cowan,
B.P. Soule, P.R. Carroll, and M.S. Litwin, Pretreatment predictors
of death from other causes in men with prostate cancer. J
Urol, 2008. 180(6): p. 2447-51; discussion 2451-2. |
|
Swanson, M.G., K.R. Keshari, Z.L. Tabatabai,
J.P. Simko, K. Shinohara, P.R. Carroll, A.S. Zektzer, and
J. Kurhanewicz, Quantification of choline- and ethanolamine-containing
metabolites in human prostate tissues using 1H HR-MAS total
correlation spectroscopy. Magn Reson Med, 2008. 60(1): p.
33-40. |
|
Walsh, T.J., B.J. Davies, M.S. Croughan,
P.R. Carroll, and P.J. Turek, Racial differences among boys
with testicular germ cell tumors in the United States. J
Urol, 2008. 179(5): p. 1961-5. |
|
Westphalen, A.C., F.V. Coakley, A.
Qayyum, M. Swanson, J.P. Simko, Y. Lu, S. Zhao, P.R.
Carroll,
B.M. Yeh, and J. Kurhanewicz, Peripheral zone prostate cancer:
accuracy of different interpretative approaches with MR and
MR spectroscopic imaging. Radiology, 2008. 246(1): p. 177-84. |
|
White, W.M., N. Sadetsky, W.B. Waters,
P.R. Carroll, and M.S. Litwin, Quality of life in men with
locally advanced adenocarcinoma of the prostate: an exploratory
analysis using data from the CaPSURE database. J Urol, 2008.
180(6): p. 2409-13; discussion 2414. |
|
Woldrich, J.M., K. Mallin, J. Ritchey,
P.R. Carroll, and C.J. Kane, Sex differences in renal cell
cancer presentation and survival: an analysis of the National
Cancer Database, 1993-2004. J Urol, 2008. 179(5): p. 1709-13;
discussion 1713. |
|
Wright, J.L., D.W. Lin, J.E. Cowan,
P.R. Carroll, and M.S. Litwin, Quality of life in young men
after radical prostatectomy. Prostate Cancer Prostatic Dis,
2008. 11(1): p. 67-73. |
|
Wu, A.K., M.R. Cooperberg, N. Sadetsky,
and P.R. Carroll, Health related quality of life in patients
treated with multimodal therapy for prostate cancer. J Urol,
2008. 180(6): p. 2415-22; discussion 2422. |
|
Zerbib, M., M.J. Zelefsky, C.S. Higano,
and P.R. Carroll, Conventional treatments of localized prostate
cancer. Urology, 2008. 72(6 Suppl): p. S25-35. |
| |
Publications – 2007 |
|
Alexander, B.M., M.H. Chen, P. Carroll,
and A.V. D'Amico, Prostate-specific antigen level at initiation
of hormonal therapy after prostate-specific antigen failure
following prostatectomy or radiotherapy and therapeutic response.
Urology, 2007. 70(2): p. 320-3. |
|
Arredondo, S.A., D.M. Latini, N. Sadetsky,
J. Kawakami, D.J. Pasta, J. DuChane, and P.R.
Carroll, Quality
of life for men receiving a second treatment for prostate
cancer. J Urol, 2007. 177(1): p. 273-8; discussion 278-9. |
|
Berglund, R.K., N. Sadetsky, J. DuChane,
P.R. Carroll, and E.A. Klein, Limited pelvic lymph node dissection
at the time of radical prostatectomy does not affect 5-year
failure rates for low, intermediate and high risk prostate
cancer: results from CaPSURE. J Urol, 2007. 177(2): p. 526-29;
discussion 529-30. |
|
Boorjian, S., J.E. Cowan, B.R. Konety,
J. DuChane, A. Tewari, P.R. Carroll, and C.J. Kane, Bladder
cancer incidence and risk factors in men with prostate cancer:
results from Cancer of the Prostate Strategic Urologic Research
Endeavor. J Urol, 2007. 177(3): p. 883-7; discussion 887-8. |
|
Coakley, F.V., I. Chen, A. Qayyum, A.C.
Westphalen, P.R. Carroll, H. Hricak, M.H. Chen, and J. Kurhanewicz,
Validity of prostate-specific antigen as a tumour marker
in men with prostate cancer managed by watchful-waiting:
correlation with findings at serial endorectal magnetic resonance
imaging and spectroscopic imaging. BJU Int, 2007. 99(1):
p. 41-5. |
|
Cooperberg, M.R., J.M. Broering, P.W. Kantoff,
and P.R. Carroll, Contemporary trends in low risk prostate cancer: risk assessment
and treatment. J Urol, 2007. 178(3
Pt 2): p. S14-9. |
|
D'Amico, A.V., D.G. McLeod, P.R.
Carroll,
J. Cullen, and M.H. Chen, Time to an undetectable prostate-specific
antigen (PSA) after androgen suppression therapy for postoperative
or postradiation PSA recurrence and prostate cancer-specific
mortality. Cancer, 2007. 109(7): p. 1290-5. |
|
Dall'Era, M. and P.R.
Carroll, Prostate
cancer--more information and more questions. J Urol, 2007.
177(5): p. 1607-8. |
|
David, K.A., M.I. Milowsky, J. Ritchey,
P.R. Carroll, and D.M. Nanus, Low incidence of perioperative
chemotherapy for stage III bladder cancer 1998 to 2003: a
report from the National Cancer Data Base. J Urol, 2007.
178(2): p. 451-4. |
|
Dewell, A., G. Weidner, M.D. Sumner, R.J.
Barnard, R.O. Marlin, J.J. Daubenmier, C. Chi, P.R. Carroll,
and D. Ornish, Relationship of dietary protein and soy isoflavones
to serum IGF-1 and IGF binding proteins in the Prostate Cancer
Lifestyle Trial. Nutr Cancer, 2007. 58(1): p. 35-42. |
|
Eggener, S.E., P.T. Scardino, P.R. Carroll,
M.J. Zelefsky, O. Sartor, H. Hricak, T.M. Wheeler, S.W. Fine,
J. Trachtenberg, M.A. Rubin, M. Ohori, K. Kuroiwa, M. Rossignol,
and L. Abenhaim, Focal therapy for localized prostate cancer:
a critical appraisal of rationale and modalities. J Urol,
2007. 178(6): p. 2260-7. |
|
Elliott, S.P., M.V. Meng, E.P. Elkin, J.W.
McAninch, J. Duchane, and P.R. Carroll, Incidence of urethral
stricture after primary treatment for prostate cancer: data
From CaPSURE. J Urol, 2007. 178(2): p. 529-34; discussion
534. |
|
Hom, J.J., F.V. Coakley, J.P. Simko, Y.
Lu, A. Qayyum, A.C. Westphalen, L.D. Schmitt, P.R.
Carroll,
and J. Kurhanewicz, High-grade prostatic intraepithelial
neoplasia in patients with prostate cancer: MR and MR spectroscopic
imaging features--initial experience. Radiology, 2007. 242(2):
p. 483-9. |
|
Kantoff, P.W., T.M. Beer, A.V. D'Amico, R.S. Dipaola,
M.A. Eisenberger, M.H. Hussain, W.K. Kelly, P. Mathew, M.J.
Morris, C.J. Ryan, H.M. Sandler, I.M. Thompson, and P.R. Carroll, Innovations
and challenges in prostate cancer: summary statement for
the 6th Cambridge Conference. J Urol, 2007. 178(3 Pt 2): p. S5-8; quiz
S4. |
|
Kawachi, M.H., R.R. Bahnson, M. Barry, P.R. Carroll,
H.B. Carter, W.J. Catalona, J.I. Epstein, R.B. Etzioni, G.P. Hemstreet,
3rd, R.J. Howe, J.D. Kopin, P.H. Lange, H. Lilja, J. Mohler, J. Moul,
R.B. Nadler, S. Patterson, A. Pollack, J.C. Presti, A.M. Stroup, D.A.
Urban, R. Wake, and J.T. Wei, Prostate cancer early detection. Clinical
practice guidelines in oncology. J Natl Compr Canc Netw, 2007. 5(7):
p. 714-36. |
|
Knight, S.J., D.M. Latini, S.L. Hart, N.
Sadetsky, C.J. Kane, J. DuChane, and P.R.
Carroll, Education
predicts quality of life among men with prostate cancer cared
for in the Department of Veterans Affairs: a longitudinal
quality of life analysis from CaPSURE. Cancer, 2007. 109(9):
p. 1769-76. |
|
Konety, B.R., V. Allareddy, and P.R.
Carroll,
Factors affecting outcomes after radical cystectomy in African
Americans. Cancer, 2007. 109(3): p. 542-8. |
|
Konety, B.R., N. Sadetsky, and P.R.
Carroll,
Recovery of urinary continence following radical prostatectomy:
the impact of prostate volume--analysis of data from the
CaPSURE Database. J Urol, 2007. 177(4): p. 1423-5; discussion
1425-6. |
|
Latini, D.M., S.L. Hart, S.J. Knight, J.E. Cowan,
P.L. Ross, J. Duchane, and P.R. Carroll, The relationship between anxiety
and time to treatment for patients with prostate cancer on surveillance.
J Urol, 2007. 178(3 Pt 1): p. 826-31; discussion 831-2. |
|
Lee, W.R., J. Sharkey, J.E. Cowan, J. DuChane,
and P.R. Carroll, Prostate brachytherapy: a descriptive analysis
from CaPSURE. Brachytherapy, 2007. 6(2): p. 123-8. |
|
Macdonald, O.K., A.V. D'Amico, N. Sadetsky, D.C. Shrieve, and P.R.
Carroll,
Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen
recurrence from the CaPSURE database. Urology, 2007. 70(1): p. 106-10. |
|
Ryan, C.J., E.P. Elkin, J. Cowan, and
P.R. Carroll, Initial treatment patterns and outcome of contemporary
prostate cancer patients with bone metastases at initial
presentation: data from CaPSURE. Cancer, 2007. 110(1): p.
81-6. |
|
Sadetsky, N., E.P. Elkin, D.M. Latini, J. Duchane,
and P.R.
Carroll, Prostate cancer outcomes among older men: insurance
status comparisons results from CaPSURE database. Prostate Cancer Prostatic
Dis, 2007. |
|
Scales, C.D., Jr., J.W. Moul, L.H. Curtis, E.P. Elkin, M.E. Hughes, and P.R.
Carroll, Prostate cancer in the Baby Boomer generation: results from CaPSURE.
Urology, 2007. 70(6): p. 1162-7. |
|
Tsai, H.K., A.V. D'Amico, N. Sadetsky, M.H. Chen, and P.R.
Carroll, Androgen
deprivation therapy for localized prostate cancer and the risk of cardiovascular
mortality. J Natl Cancer Inst, 2007. 99(20): p. 1516-24. |
|
Walsh, T.J., M.A. Dall'Era, M.S. Croughan, P.R.
Carroll, and P.J. Turek,
Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of
testicular cancer. J Urol, 2007. 178(4 Pt 1): p. 1440-6; discussion 1446. |
|
Wilson, L.S., R. Tesoro, E.P. Elkin, N.
Sadetsky, J.M. Broering, D.M. Latini, J. DuChane, R.R. Mody,
and P.R. Carroll, Cumulative cost pattern comparison of prostate
cancer treatments. Cancer, 2007. 109(3): p. 518-27. |
|
Wright, J.L., D.W. Lin, J.E. Cowan, P.R.
Carroll, and M.S. Litwin, Quality of life in young men after
radical prostatectomy. Prostate Cancer Prostatic Dis, 2007. |
| |
return
to top
|
|
|
|
|
|
|
